|
CSRNP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.718210E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.051200E-01 |
| Normal-vs-Stage2 |
3.286100E-02 |
| Normal-vs-Stage3 |
3.60460000000673E-05 |
| Normal-vs-Stage4 |
1.90200000005358E-06 |
| Stage1-vs-Stage2 |
2.307400E-01 |
| Stage1-vs-Stage3 |
3.08410000005033E-06 |
| Stage1-vs-Stage4 |
9.66269999569391E-08 |
| Stage2-vs-Stage3 |
1.116030E-01 |
| Stage2-vs-Stage4 |
3.138300E-02 |
| Stage3-vs-Stage4 |
3.286400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.580900E-04 |
| Normal-vs-AfricanAmerican |
4.969800E-01 |
| Normal-vs-Asian |
2.08829999999161E-05 |
| Caucasian-vs-AfricanAmerican |
1.429550E-01 |
| Caucasian-vs-Asian |
5.799900E-03 |
| AfricanAmerican-vs-Asian |
1.583260E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.363300E-04 |
| Normal-vs-Female |
2.482600E-01 |
| Male-vs-Female |
1.042510E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.121600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.066210E-02 |
| Normal-vs-Age(61-80Yrs) |
4.977900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.674200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.715800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.140200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.620000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.199400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.137800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.748600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.188000E-01 |
| Normal-vs-Grade 2 |
1.771790E-01 |
| Normal-vs-Grade 3 |
1.156670E-04 |
| Normal-vs-Grade 4 |
4.11899999996912E-06 |
| Grade 1-vs-Grade 2 |
1.701990E-01 |
| Grade 1-vs-Grade 3 |
4.659600E-02 |
| Grade 1-vs-Grade 4 |
2.792400E-02 |
| Grade 2-vs-Grade 3 |
4.38670000000307E-05 |
| Grade 2-vs-Grade 4 |
1.79410000000768E-06 |
| Grade 3-vs-Grade 4 |
1.621600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.393800E-02 |
| Normal-vs-ccB subtype |
1.791460E-04 |
| ccA subtype-vs-ccB subtype |
5.790500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.902900E-03 |
| Normal-vs-N1 |
4.64269733768674E-11 |
| N0-vs-N1 |
2.21400675570749E-12 |
|
|
